No abstract available
Keywords:
Crizotinib; Generation sequencin; Lung large-cell neuroendocrine carcinoma; PLB1-ALK; Sensitivity.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Anaplastic Lymphoma Kinase / genetics
-
Carcinoma, Large Cell / drug therapy*
-
Carcinoma, Large Cell / genetics
-
Carcinoma, Large Cell / pathology
-
Carcinoma, Neuroendocrine / drug therapy*
-
Carcinoma, Neuroendocrine / genetics
-
Carcinoma, Neuroendocrine / pathology
-
Crizotinib / pharmacology*
-
Gene Rearrangement
-
High-Throughput Nucleotide Sequencing
-
Humans
-
Lung Neoplasms / drug therapy*
-
Lung Neoplasms / genetics
-
Lung Neoplasms / pathology
-
Lysophospholipase / genetics
-
Male
-
Protein Kinase Inhibitors / pharmacology
Substances
-
Protein Kinase Inhibitors
-
Crizotinib
-
ALK protein, human
-
Anaplastic Lymphoma Kinase
-
Lysophospholipase